Brand R - Search Results

1

MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.

Farchoukh L, Kuan SF, Dudley B, Brand R, Nikiforova M, Pai RK. Farchoukh L, et al. Among authors: brand r. Am J Surg Pathol. 2016 Oct;40(10):1390-9. doi: 10.1097/PAS.0000000000000695. Am J Surg Pathol. 2016. PMID: 27438990

2

MUTYH exon 7 and 13 mutations associated with colorectal cancer (MAP syndrome) are not commonly associated with sporadic pancreatic cancer.

Smith LM, Sharif S, Brand R, Fink E, Lamb J, Whitcomb DC. Smith LM, et al. Among authors: brand r. Pancreatology. 2009;9(6):793-6. doi: 10.1159/000199440. Epub 2010 Jan 28. Pancreatology. 2009. PMID: 20110747

3

Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome-associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency.

Xia M, Singhi AD, Dudley B, Brand R, Nikiforova M, Pai RK. Xia M, et al. Among authors: brand r. Appl Immunohistochem Mol Morphol. 2017 Jul;25(6):399-406. doi: 10.1097/PAI.0000000000000389. Appl Immunohistochem Mol Morphol. 2017. PMID: 27258561

4

Neoadjuvant therapy in microsatellite-stable colorectal carcinoma induces concomitant loss of MSH6 and Ki-67 expression.

Kuan SF, Ren B, Brand R, Dudley B, Pai RK. Kuan SF, et al. Among authors: brand r. Hum Pathol. 2017 May;63:33-39. doi: 10.1016/j.humpath.2017.02.003. Epub 2017 Feb 21. Hum Pathol. 2017. PMID: 28232158

5

Prospective study of germline genetic testing in incident cases of pancreatic adenocarcinoma.

Brand R, Borazanci E, Speare V, Dudley B, Karloski E, Peters MLB, Stobie L, Bahary N, Zeh H, Zureikat A, Hogg M, Lee K, Tsung A, Rhee J, Ohr J, Sun W, Lee J, Moser AJ, DeLeonardis K, Krejdovsky J, Dalton E, LaDuca H, Dolinsky J, Colvin A, Lim C, Black MH, Tung N. Brand R, et al. Cancer. 2018 Sep 1;124(17):3520-3527. doi: 10.1002/cncr.31628. Epub 2018 Aug 1. Cancer. 2018. PMID: 30067863 Free article.

6

Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.

Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A. Singhi AD, et al. Among authors: brand r. Gut. 2020 Jan;69(1):52-61. doi: 10.1136/gutjnl-2018-317817. Epub 2019 Apr 10. Gut. 2020. PMID: 30971436 Free PMC article.

7

Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.

Peters MLB, Stobie L, Dudley B, Karloski E, Allen K, Speare V, Dolinsky JS, Tian Y, DeLeonardis K, Krejdovsky J, Button A, Lim C, Borazanci E, Brand R, Tung N. Peters MLB, et al. Among authors: brand r. Cancer. 2019 Jul 15;125(14):2488-2496. doi: 10.1002/cncr.32077. Epub 2019 Apr 12. Cancer. 2019. PMID: 30980401 Free article.

8

The impact of genetic counseling on patient engagement in a specialty cancer clinic.

Zakas AL, Leifeste C, Dudley B, Karloski E, Afonso S, Grubs RE, Shaffer JR, Durst AL, Parkinson MD, Brand R. Zakas AL, et al. Among authors: brand r. J Genet Couns. 2019 Oct;28(5):974-981. doi: 10.1002/jgc4.1149. Epub 2019 Jul 11. J Genet Couns. 2019. PMID: 31293033

9

Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.

Hackeng WM, Brosens LAA, Kim JY, O'Sullivan R, Sung YN, Liu TC, Cao D, Heayn M, Brosnan-Cashman J, An S, Morsink FHM, Heidsma CM, Valk GD, Vriens MR, Nieveen van Dijkum E, Offerhaus GJA, Dreijerink KMA, Zeh H, Zureikat AH, Hogg M, Lee K, Geller D, Marsh JW, Paniccia A, Ongchin M, Pingpank JF, Bahary N, Aijazi M, Brand R, Chennat J, Das R, Fasanella KE, Khalid A, McGrath K, Sarkaria S, Singh H, Slivka A, Nalesnik M, Han X, Nikiforova MN, Lawlor RT, Mafficini A, Rusev B, Corbo V, Luchini C, Bersani S, Pea A, Cingarlini S, Landoni L, Salvia R, Milione M, Milella M, Scarpa A, Hong SM, Heaphy CM, Singhi AD. Hackeng WM, et al. Among authors: brand r. Gut. 2022 May;71(5):961-973. doi: 10.1136/gutjnl-2020-322595. Epub 2021 Apr 13. Gut. 2022. PMID: 33849943 Free PMC article.

10

Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection Consortium.

Gonda TA, Farrell J, Wallace M, Khanna L, Janec E, Kwon R, Saunders M, Siddiqui UD, Brand R, Simeone DM; PRECEDE Consortium. Gonda TA, et al. Among authors: brand r. Gastrointest Endosc. 2022 Apr;95(4):723-732.e7. doi: 10.1016/j.gie.2021.10.025. Epub 2021 Nov 2. Gastrointest Endosc. 2022. PMID: 34736932

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,256 results

Search Page

Filters